CROI 2017 Program and Information

Program and Agenda

227 EFFECT OF EXOGENOUS INTERFERON ALPHA ONHIV VIRAL POPULATIONS INVIVO Giorgio Bozzi 1 , Wei Shao 2 , Robin L. Dewar 2 , Vinay K. Pathak 1 , Belete A. Desimmie 1 , Ryan C. Burdick 1 , Sara Jones 3 , Claudia Balotta 4 , Mary E. Wright 5 , Frank Maldarelli 1 1 NCI, Frederick, MD, USA, 2 Leidos Biomed Rsr, Inc, Frederick, MD, USA, 3 Leidos BiomedRsr,Inc,Bethesda,MD,USA, 4 UnivofMilan,Milan,Italy, 5 NIAID,Bethesda,MD, USA Poster P-D1: HIV-SPECIFIC ANTIBODIES AND HOW TO INDUCE THEM Poster Hall - 4 EF 2:30 PM - 4:00 PM 242 A BROAD POLYCLONAL RESPONSE ISMEDIATED BY SUPERINFECTIONWITH2 DISTINCT VIRUSES Bingjie Wang 1 , Katherine L. Williams 1 , Valerie Cortez 1 , James A. Williams 2 , Kelly K. Lee 2 , R. Scott McClelland 2 , Julie Overbaugh 1 1 Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA, 2 Univ of Washington, Seattle, WA, USA 243 HIGH-RESOLUTIONMAPPING OF AN ENV EPITOPE BY COMPREHENSIVE ESCAPEMUTANT SELECTION Adam Dingens , Hugh Haddox, Julie Overbaugh, Jesse Bloom Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA 244 INITIAL HIV DIVERSITY &NEUTRALIZING ANTIBODY DEVELOPMENT IN PEOPLEWHO INJECT DRUGS Andrew D. Redd 1 , Nicole Doria-Rose 2 , Matthew Seivers 3 , Stephen Schmidt 1 , Oliver Laeyendecker 1 , Stephen Porcella 4 , Gregory D. Kirk 3 , John R. Mascola 5 , Shruti H. Mehta 3 , Thomas C. Quinn 1 1 NIAID, Bethesda, MD, USA, 2 NIH, Bethesda, MD, USA, 3 The Johns Hopkins Univ, Baltimore, MD, USA, 4 NIAID, Hamilton, MT, USA, 5 Vaccine Rsr Cntr, Bethesda, MD, USA 245 ELITE NEUTRALIZATION AND UNIQUE EPITOPE SPECIFICITY OF A VIREMIC NONPROGRESSOR Nandagopal Paneerselvam 1 , Chinnambedu Ravichandran Swathirajan 1 , Sunil S. Solomon 1 , Jayantha Bhattacharya 2 , Bimal K. Chakrabarti 2 , Rajat Goyal 3 , Aylur K. Srikrishnan 1 , Kailapuri G. Murugavel 1 1 YRG CARE, Chennai, India, 2 HIV Vaccine Translational Rsr Lab, Faridabad, India, 3 Intl AIDS Vaccine Initiative, New York, NY, USA 246 USING EMPIRIC SATURATIONMUTAGENESIS TO IDENTIFY NOVEL ENV TRIMERS FOR VACCINES Maria Jose Duenas Decamp 1 , Li Jiang 2 , Dan Bolon 1 , Paul Clapham 1 1 Univ of Massachusetts, Worcester, MA, USA, 2 Harvard Univ, Boston, MA, USA

Poster Sessions • Tuesday

247 OLEANOLIC ACID DERIVATIVE OKS3-019 AS A NOVEL BIFUNCTIONAL HIV-1 ENTRY INHIBITOR

Shigeyoshi Harada 1 , Kasumi Ogihara 2 , Yuta Hikichi 1 , Tetsuro Matano 1 , Tetsuo Narumi 2 , Kazuhisa Yoshimura 1 1 Natl Inst of Infectious Diseases, Shinjuku-ku, Tokyo, Japan, 2 Shizuoka Univ, Hamamatsu, Shizuoka, Japan

248 GP41 ANTIGENIC RECOGNITION AND RESPONSE INHIV- NEGATIVEMENWHO HAVE SEXWITHMEN

Katie McFaul , Jia Guo, Elizabeth Atkins, Xiao-Ning Xu, Peter Kelleher, for the Centre for Immunology and Vaccinology Imperial Coll London, London, UK

CROI 2017 77